Results 181 to 190 of about 67,397 (310)

Vitamin D Deficiency as a Risk Factor for Onset and Recurrence of Sudden Sensorineural Hearing Loss: A Prospective Cohort Study With Age‐Specific Analysis

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Pure‐tone audiometry (0–120 dB HL) identified patients with sudden sensorineural hearing loss (SSNHL). Serum 25‐hydroxyvitamin D levels revealed deficient (< 20 ng/mL), insufficient (20–30 ng/mL), or sufficient (≥ 30 ng/mL) status. Novel findings demonstrate low vitamin D correlates with higher SSNHL onset/recurrence, particularly elevating risk in ...
Qi Hui   +8 more
wiley   +1 more source

Navigating the evolving management of smoldering multiple myeloma

open access: yesHemaSphere, Volume 10, Issue 1, January 2026.
Abstract Smoldering multiple myeloma (SMM) represents an intermediate clinical stage between monoclonal gammopathy of undetermined significance (MGUS) and symptomatic multiple myeloma (MM). SMM carries a highly variable risk of progression to MM, requiring individualized risk stratification to guide management.
M. Bakri Hammami   +6 more
wiley   +1 more source

A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.

open access: yesJournal of the American Society of Nephrology, 2016
J. Cruzado   +12 more
semanticscholar   +1 more source

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B‐Cell Lymphoma in the Real‐Life Patient Journey

open access: yesHematological Oncology, Volume 44, Issue 1, January 2026.
ABSTRACT The combination of tafasitamab and lenalidomide (tafa‐lena) has demonstrated efficacy in relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL), as evidenced by the L‐MIND study. To investigate the therapeutic potential and safety profile of tafa‐lena in real‐life, we conducted a national multicentric retrospective study.
Lisa Argnani   +34 more
wiley   +1 more source

24R,25(OH)2D3 regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane‐associated receptor complexes in ER+ and ER− cells

open access: yesInternational Journal of Cancer, Volume 158, Issue 1, Page 202-217, 1 January 2026.
What's new? Estrogen receptors likely influence the development of laryngeal cancer and are of particular interest in regard to their relationship with the vitamin D metabolite 24R,25(OH)2D3. In this study the authors examined interactions between 24R,25(OH)2D3 and estrogen‐responsive laryngeal tumorigenesis.
Cydney D. Dennis   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy